RXRX NASDAQ
Recursion Pharmaceuticals, Inc.
1W: +2.3%
1M: -16.6%
3M: -9.1%
YTD: -25.9%
1Y: -31.6%
3Y: -39.4%
5Y: -85.3%
$3.01
-0.10 (-3.22%)
Weekly Expected Move ±7.1%
$3
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$66M
Revenue
+11.0% YoY
$-560M
Net Income
+2.6% YoY
$-326M
Free Cash Flow
+18.8% YoY
-93.0%
Gross Margin
-1985.6%
Op. Margin
-1815.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-51.7%
ROA-38.3%
ROIC-99.3%
Valuation
P/E-2.8
P/B1.6
EV/EBITDA-2.0
Leverage
Debt/Equity0.07
Current Ratio5.50
Interest Cov.-342.9x
Quality Scores
Piotroski F5/9
Altman Z0.18
Beneish M-3.95